For citations:
Krylova Ya.V., Kondakova E.V., Gavrilenko A.N., Chekalov A.M., Fedorova L.V., Stelmakh L.V., Babenko E.V., Shchegoleva T.S., Gusak A.A., Baykov V.V., Mikhailova N.B., Kulagin A.D. Mosunetuzumab for relapsed or refractory follicular lymphoma: a case study. Oncohematology. 2024;19(3):153-158. (In Russ.) https://doi.org/10.17650/1818-8346-2024-19-3-153-158